- Home
- HNNA vs ANIX Comparison
HNNA vs ANIX Comparison
Compare HNNA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- ANIX
- Stock Information
- Founded
- HNNA 1989
- ANIX 1982
- Country
- HNNA United States
- ANIX United States
- Employees
- HNNA N/A
- ANIX N/A
- Industry
- HNNA Investment Managers
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- HNNA Finance
- ANIX Health Care
- Exchange
- HNNA Nasdaq
- ANIX Nasdaq
- Market Cap
- HNNA 98.7M
- ANIX 108.9M
- IPO Year
- HNNA N/A
- ANIX 1987
- Fundamental
- Price
- HNNA $10.67
- ANIX $2.97
- Analyst Decision
- HNNA
- ANIX Strong Buy
- Analyst Count
- HNNA 0
- ANIX 3
- Target Price
- HNNA N/A
- ANIX $9.00
- AVG Volume (30 Days)
- HNNA 12.2K
- ANIX 92.2K
- Earning Date
- HNNA 08-06-2025
- ANIX 09-05-2025
- Dividend Yield
- HNNA 5.15%
- ANIX N/A
- EPS Growth
- HNNA 56.56
- ANIX N/A
- EPS
- HNNA 1.25
- ANIX N/A
- Revenue
- HNNA $35,816,000.00
- ANIX N/A
- Revenue This Year
- HNNA N/A
- ANIX N/A
- Revenue Next Year
- HNNA N/A
- ANIX N/A
- P/E Ratio
- HNNA $8.54
- ANIX N/A
- Revenue Growth
- HNNA 32.04
- ANIX N/A
- 52 Week Low
- HNNA $8.43
- ANIX $2.07
- 52 Week High
- HNNA $13.88
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- HNNA 30.78
- ANIX 42.09
- Support Level
- HNNA $10.42
- ANIX $3.00
- Resistance Level
- HNNA $11.20
- ANIX $3.10
- Average True Range (ATR)
- HNNA 0.76
- ANIX 0.16
- MACD
- HNNA -0.24
- ANIX -0.02
- Stochastic Oscillator
- HNNA 9.65
- ANIX 16.28
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.